Skip to search formSkip to main contentSkip to account menu

DA 6034

Known as: DA-6034 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2014
2014
DA-6034-induced mucin secretion via Ca2+-dependent pathways through P2Y receptor stimulation.
PURPOSE We evaluated whether DA-6034 is involved in mucin secretion via P2Y receptor activation and/or intracellular Ca2… 
2009
2009
Effects of DA-6034, a Flavonoid Derivative, on Mucin-like Glycoprotein and Ocular Surface Integrity in a Rabbit Model
Abstract This study was designed to assess whether DA-6034 (7-carboxymethyloxy-3′,4′,5-trimethoxy flavone monohydrate), a new… 
2008
2008
DA-6034, a Derivative of Flavonoid, Prevents and Ameliorates Dextran Sulfate Sodium–Induced Colitis and Inhibits Colon Carcinogenesis
Previously, we have shown that DA-6034, a synthetic derivative of flavonoid eupatilin, inhibited NF-κB activation in colon… 
2008
2008
The effects of DA-6034 on NF-kappaB activity induced by lipopolysaccharide or tumor necrosis factor alpha in a human colonic epithelial cell line.
BACKGROUND/AIMS DA-6034, a synthetic derivative of eupatilin, has shown a potent anti-inflammatory effect in experimental rat… 
2007
2007
Inhibitory Effects of 7‐Carboxymethyloxy‐3′,4′,5‐Trimethoxy Flavone (DA‐6034) on Helicobacter pylori‐Induced NF‐κB Activation and iNOS Expression in AGS Cells
Abstract:  The Helicobacter pylori were identified by Marshall and Warren in 1984. H. pylori survive in the forbidding harsh acid… 
2006
2006
Pharmacokinetics of 7‐carboxymethyloxy‐3‘,4’,5‐trimethoxy flavone (DA‐6034), a derivative of flavonoid, in mouse and rat models of chemically‐induced inflammatory bowel disease
The pharmacokinetics (including distribution in the gastrointestinal tract) of 7‐carboxymethyloxy‐3‘,4’,5‐trimethoxy flavone (DA… 
2006
2006
Gender differences in the pharmacokinetics of DA-6034, a derivative of flavonoids, in rats.
Gender differences in the pharmacokinetics of DA-6034 were evaluated after intravenous and oral administration at a dose of 50 mg… 
2006
2006
Pharmacokinetics of DA-6034, an agent for inflammatory bowel disease, in rats and dogs: Contribution of intestinal first-pass effect to low bioavailability in rats
2005
2005
The Effect of DA-6034, a Synthetic Derivative of Flavonoid, on NF-κB Activity Stimulated with Lipopolysaccharide and Tumor Necrosis actor-α in Human Colonic Epithelial Cell Line
1998
1998
The Effect of DA-6034, Eupatilin Derivatives of Flavonoids, on the Rats with Trinitrobenzene Sulfonic Acid (TNBS) - Induced Colitis
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)